Literature DB >> 25125653

Draft Genome Sequence of Rifamycin Derivatives Producing Amycolatopsis mediterranei Strain DSM 46096/S955.

Priya Singh1, Rashmi Kumari1, Udita Mukherjee1, Anjali Saxena1, Utkarsh Sood1, Rup Lal2.   

Abstract

Amycolatopsis mediterranei DSM 46096 produces antibiotics of the rifamycin family, 27-demethoxy-27-hydroxyrifamycin B, 25-desacetyl-27-demethoxy-27-hydroxyrifamycin, and 27-demethoxy-27-hydroxyrifamycin SV, which are effective against Gram-negative bacteria. Here, we present the draft genome of A. mediterranei 46096 (approx. 10.2 Mbp) having 104 contigs with a GC content of 71.3% and 9,382 coding sequences.
Copyright © 2014 Singh et al.

Entities:  

Year:  2014        PMID: 25125653      PMCID: PMC4132629          DOI: 10.1128/genomeA.00837-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Rifamycins are produced commercially by several strains of Amycolatopsis mediterranei. Semisynthetic derivatives of rifamycin are used for curing tuberculosis and leprosy. There is ambiguity about the origin of these strains, which moved from one industry to another during the past 50 years. In an attempt to further analyze these strains we initially did the taxonomical characterization (1) and then sequenced the genomes of A. mediterranei S699 (2), 46095 (3), and 40773 (4). One strain of A. mediterranei that originated during mutagenesis of wild-type A. mediterranei 43304 (ME/83) (5) with N-methyl-N-nitro-N-nitrosoguanidine at Lepetit laboratory, is A. mediterranei 46096. Its significance lies in its ability to produce antibiotics of the rifamycin family, 27-demethoxy-27-hydroxyrifamycin SV, 27-demethoxy-27-hydroxyrifamycin B, and 25-desacetyl-27-demethoxy-27-hydroxyrifamycin, which are effective against Gram-negative bacteria (6). Due to the severe problem of tuberculosis and the need for the production of analogues of rifamycin, there is a renewed interest in research on A. mediterranei. While during the past 30 years emphasis has been on the development of cloning vectors and a transformation system for this group of organisms (7–11) and on the characterization of the rifPKS gene cluster (12–14), the genomes of some of strains, including S699 (2), 46095 (3), 40773 (4), U32 (15), and RB (CP003777), have recently been sequenced. We report here the draft genome sequence of A. mediterranei 46096. A. mediterranei 46096 genomic DNA was sequenced by Illumina Genome Analyzer IIx, which generated approximately 2.3 Gb of data (500 bp and 2 kb paired-end libraries) using a PCR-free approach. Sequence coverage of more than 100× was obtained, corresponding to 25,763,590 pair-end reads. Raw reads were assembled into contigs (n = 104, >500 bp) using ABySS software version 1.3.5 (16), set at a k-mer length of 63. The assembled genome had N50 value of 462 kb and an average GC content of 71.3%. The draft genome was annotated using RAST version 4.0 (17) and NCBI Prokaryotic Genome Annotation Pipeline (PGAP) version 2.1 (http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline.html), which identified 9,382 protein-coding genes and 24 pseudogenes. Using PGAP annotations, 15 rRNA and 52 tRNA genes were also predicted. Using antiSMASH (Antibiotic and Secondary Metabolites Analysis Shell) (18), 37 secondary metabolite gene clusters were found that encode 7 type I and II polyketide synthases (PKS), 12 nonribosomal peptide synthetases (NRPSs), 2 NRPS/PKS, lantipeptides, bacteriocin, etc. The rifPKS gene cluster was identical to the earlier reported rifPKS (12), except for the rifB gene, which was 99% similar. Additionally, one CRISPR element and 1,212 tandem repeats were also identified in the draft genome. Average nucleotide identity (ANI) (19) revealed that A. mediterranei 46096 is highly similar to A. mediterranei U32 (99.9%) (15), S699 (99.9%) (2), RB (CP003777), and 40773 (approx. 99.9%) (4) but substantially differs from 46095 (approx. 92.5%) (3). With the availability of the genome sequences of the above-mentioned strains of A. mediterranei, including DSM 46096, comparative genomics studies are now under way to better understand the variations in polyketide synthase gene clusters and related genome characteristics. The analysis will further resolve the issue of origin of these strains hitherto unknown and to perform combinatorial biosynthesis for the production of rifamycin analogues (20).

Nucleotide sequence accession numbers.

The draft genome sequence of A. mediterranei DSM 46096 is available in GenBank database under accession number JMQG00000000. The version described in this paper is JMQG01000000.
  18 in total

1.  Development of cloning vectors and transformation methods for Amycolatopsis.

Authors:  Gauri Dhingra; Rekha Kumari; Shashi Bala; Swati Majumdar; Shweta Malhotra; Poonam Sharma; Sukanya Lal; John Cullum; Rup Lal
Journal:  J Ind Microbiol Biotechnol       Date:  2003-04-08       Impact factor: 3.346

2.  Construction of a hybrid plasmid capable of replication in Amycolatopsis mediterranei.

Authors:  R Lal; S Lal; E Grund; R Eichenlaub
Journal:  Appl Environ Microbiol       Date:  1991-03       Impact factor: 4.792

3.  Towards a genome-based taxonomy for prokaryotes.

Authors:  Konstantinos T Konstantinidis; James M Tiedje
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

4.  Cloning and sequence analysis of the putative rifamycin polyketide synthase gene cluster from Amycolatopsis mediterranei.

Authors:  T Schupp; C Toupet; N Engel; S Goff
Journal:  FEMS Microbiol Lett       Date:  1998-02-15       Impact factor: 2.742

5.  Cloning and partial characterization of the putative rifamycin biosynthetic gene cluster from the actinomycete Amycolatopsis mediterranei DSM 46095.

Authors:  H Kaur; J Cortes; P Leadlay; R Lal
Journal:  Microbiol Res       Date:  2001       Impact factor: 5.415

6.  Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism.

Authors:  Wei Zhao; Yi Zhong; Hua Yuan; Jin Wang; Huajun Zheng; Ying Wang; Xufeng Cen; Feng Xu; Jie Bai; Xiaobiao Han; Gang Lu; Yongqiang Zhu; Zhihui Shao; Han Yan; Chen Li; Nanqiu Peng; Zilong Zhang; Yunyi Zhang; Wei Lin; Yun Fan; Zhongjun Qin; Yongfei Hu; Baoli Zhu; Shengyue Wang; Xiaoming Ding; Guo-Ping Zhao
Journal:  Cell Res       Date:  2010-06-22       Impact factor: 25.617

7.  Development of an improved cloning vector and transformation system in Amycolatopsis mediterranei (Nocardia mediterranei).

Authors:  R Lal; R Khanna; N Dhingra; M Khanna; S Lal
Journal:  J Antibiot (Tokyo)       Date:  1998-02       Impact factor: 2.649

8.  Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699.

Authors:  P R August; L Tang; Y J Yoon; S Ning; R Müller; T W Yu; M Taylor; D Hoffmann; C G Kim; X Zhang; C R Hutchinson; H G Floss
Journal:  Chem Biol       Date:  1998-02

9.  Draft Genome Sequence of the Rifamycin Producer Amycolatopsis rifamycinica DSM 46095.

Authors:  Anjali Saxena; Rashmi Kumari; Udita Mukherjee; Priya Singh; Rup Lal
Journal:  Genome Announc       Date:  2014-07-03

10.  Draft Genome Sequence of Amycolatopsis mediterranei DSM 40773, a Tangible Antibiotic Producer.

Authors:  Udita Mukherjee; Anjali Saxena; Rashmi Kumari; Priya Singh; Rup Lal
Journal:  Genome Announc       Date:  2014-07-31
View more
  2 in total

1.  Genetics and Genomics of the Genus Amycolatopsis.

Authors:  Rashmi Kumari; Priya Singh; Rup Lal
Journal:  Indian J Microbiol       Date:  2016-05-02       Impact factor: 2.461

Review 2.  Chicken Gut Microbiome and Human Health: Past Scenarios, Current Perspectives, and Futuristic Applications.

Authors:  Utkarsh Sood; Vipin Gupta; Roshan Kumar; Sukanya Lal; Derek Fawcett; Supriya Rattan; Gerrard Eddy Jai Poinern; Rup Lal
Journal:  Indian J Microbiol       Date:  2019-02-08       Impact factor: 2.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.